How Will the Market React to Sio Gene Therapies Inc (SIOX) Stock Getting a Bearish Rating

Thursday, March 23, 2023 12:51 PM | InvestorsObserver Analysts

Mentioned in this article

How Will the Market React to Sio Gene Therapies Inc (SIOX) Stock Getting a Bearish Rating

The market has been down on Sio Gene Therapies Inc (SIOX) stock recently. SIOX gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Sio Gene Therapies Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on SIOX!

See Full SIOX Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With SIOX Stock Today?

Sio Gene Therapies Inc (SIOX) stock is trading at $0.42 as of 4:00 PM on Wednesday, Mar 22, an increase of $0.01, or 2.09% from the previous closing price of $0.41. Volume today is elevated. So far 3,352,499 shares have traded compared to average volume of 554,711 shares. The stock has traded between $0.41 and $0.44 so far today. To screen for more stocks like Sio Gene Therapies Inc click here.

More About Sio Gene Therapies Inc

Sio Gene Therapies Inc is a clinical-stage company that is focused on gene therapy for neurodegenerative diseases. The company is developing its pipeline for the treatment of debilitating diseases, including Parkinson's disease, GM1 gangliosidosis, and GM2 gangliosidosis. Click Here to get the full Stock Report for Sio Gene Therapies Inc stock.